Jan P van Meerbeeck
Jan P van Meerbeeck
Universiteit Antwerpen - Universitair Ziekenhuis Antwerpen- Universiteit Gent
Geverifieerd e-mailadres voor uza.be
Geciteerd door
Geciteerd door
The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...
Journal of Thoracic Oncology 11 (1), 39-51, 2016
Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer
International Adjuvant Lung Cancer Trial Collaborative Group
New England Journal of Medicine 350 (4), 351-360, 2004
First-line nivolumab in stage IV or recurrent non–small-cell lung cancer
DP Carbone, M Reck, L Paz-Ares, B Creelan, L Horn, M Steins, E Felip, ...
New England Journal of Medicine 376 (25), 2415-2426, 2017
Small-cell lung cancer
JP Van Meerbeeck, DA Fennell, DKM De Ruysscher
The Lancet 378 (9804), 1741-1755, 2011
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non–small-cell lung cancer
JP Van Meerbeeck, GWPM Kramer, PEY Van Schil, C Legrand, EF Smit, ...
Journal of the National Cancer Institute 99 (6), 442-450, 2007
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A Scherpereel, P Astoul, P Baas, T Berghmans, H Clayson, P De Vuyst, ...
European Respiratory Journal 35 (3), 479-495, 2010
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for …
JP van Meerbeeck, R Gaafar, C Manegold, RJ Van Klaveren, ...
Journal of Clinical Oncology 23 (28), 6881-6889, 2005
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial
JT Annema, JP Van Meerbeeck, RC Rintoul, C Dooms, E Deschepper, ...
Jama 304 (20), 2245-2252, 2010
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
NSCLC Meta-analyses Collaborative Group
The Lancet 375 (9722), 1267-1277, 2010
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
MC Garassino, JG Whisenant, LC Huang, A Trama, V Torri, F Agustoni, ...
The Lancet Oncology 21 (7), 914-922, 2020
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
D Curran, T Sahmoud, P Therasse, J van Meerbeeck, PE Postmus, ...
Journal of Clinical Oncology 16 (1), 145-152, 1998
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
PK Paik, E Felip, R Veillon, H Sakai, AB Cortot, MC Garassino, J Mazieres, ...
New England Journal of Medicine 383 (10), 931-943, 2020
The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth …
WD Travis, H Asamura, AA Bankier, MB Beasley, F Detterbeck, DB Flieder, ...
Journal of Thoracic Oncology 11 (8), 1204-1223, 2016
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
L Crino, W Weder, J Van Meerbeeck, E Felip
Annals of oncology 21, v103-v115, 2010
Proteomic analysis of exosomes isolated from human malignant pleural effusions
MP Bard, JP Hegmans, A Hemmes, TM Luider, R Willemsen, ...
American journal of respiratory cell and molecular biology 31 (1), 114-121, 2004
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
C Faivre-Finn, M Snee, L Ashcroft, W Appel, F Barlesi, A Bhatnagar, ...
The Lancet Oncology 18 (8), 1116-1125, 2017
The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer
K Chansky, JP Sculier, JJ Crowley, D Giroux, J Van Meerbeeck, ...
Journal of thoracic oncology 4 (7), 792-801, 2009
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European …
EF Smit, J Van Meerbeeck, P Lianes, C Debruyne, C Legrand, ...
Journal of Clinical Oncology 21 (21), 3909-3917, 2003
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of …
D Gilligan, M Nicolson, I Smith, H Groen, O Dalesio, P Goldstraw, ...
The Lancet 369 (9577), 1929-1937, 2007
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ...
Lung cancer 47 (1), 69-80, 2005
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20